| Advantages | They are ideal for disease modeling, drug testing, and investigating pancreatic duct responses to therapeutic interventions. Compared to traditional 2D cultures, these organoids offer a more accurate representation of human pancreatic tissue. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Pancreatic Duct |
| Disease | Normal |
| Format | Frozen |
| Organoid Characterization | They recapitulate key features of the pancreatic ductal epithelium, including ductal structures, acinar cells, and endocrine components, while preserving the pancreatic microenvironment. These organoids provide a physiologically relevant platform for studying pancreatic development, ductal diseases, and pancreatic cancer such as ductal adenocarcinoma. |
| Applications | Tissue-derived organoids are broadly utilized in drug screening, disease modeling, mechanistic studies, personalized medicine, and regenerative medicine. By faithfully modeling disease states, they provide an ideal platform for evaluating patient-specific drug responses and informing personalized treatment design. Additionally, these organoids enable the development of novel therapeutic approaches, particularly in oncology and tissue regeneration, offering precise experimental tools that accelerate progress in precision medicine. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.